Literature DB >> 1083546

Abnormal pulmonary gallium accumulation in P. carinii pneumonia.

S M Levenson, R D Warren, S D Richman, G S Johnston, B A Chabner.   

Abstract

The potentially fatal interstitial pneumonia of Pneumocystis carinii is a frequent opportunistic invader of patients treated for malignancy with immunosuppressive and cytotoxic agents. Generalized Ga-67 pulmonary localization which is markedly disproportionate to the clinical and radiographic findings has led to earlier diagnoses by open lung biopsy in this setting. The potential usefulness of gallium scintigraphy in patients with suspected P. Carini pneumonia is presented.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083546     DOI: 10.1148/119.2.395

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Thoracic imaging with gallium-67.

Authors:  H Klech; H Köhn; M Huppmann; W Pohl
Journal:  Eur J Nucl Med       Date:  1987

2.  Sensitivity of 67Ga-scanning in sarcoidosis: detection of biopsy proven pulmonary lesions radiographically undetectable.

Authors:  D Beaumont; J Y Herry; J le Cloirec; J J le Jeune; B de Labarthe
Journal:  Eur J Nucl Med       Date:  1982

3.  Pulmonary uptake in 67-gallium citrate scintigraphy-the 'negative heart' sign.

Authors:  S G Cooke; E R Davies; P R Goddard
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

4.  Value of 67gallium scintigraphy in primary diagnosis and follow-up of opportunistic pneumonia in patients with AIDS.

Authors:  E Moser; K Tatsch; C M Kirsch; G Küffer; F D Goebel
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Lung mechanics, radiography and 67Ga scintigraphy in experimental Pneumocystis carinii pneumonia.

Authors:  D C Stokes; W T Hughes; P O Alderson; R E King; D J Garfinkel
Journal:  Br J Exp Pathol       Date:  1986-06

6.  Gallium-67 citrate imaging for the assessment of radiation pneumonitis.

Authors:  M Kataoka
Journal:  Ann Nucl Med       Date:  1989-07       Impact factor: 2.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.